Abstract 172: Projected Number of HF Admissions Per Heart Failure Patient In The Medicare Population

Autor: Phillip R Hunt, Ning Wu, Barbara K Veath, Stelios Tsintzos, Mark L Burton, Sara A Mollenkopf
Rok vydání: 2013
Předmět:
Zdroj: Circulation: Cardiovascular Quality and Outcomes. 6
ISSN: 1941-7705
1941-7713
DOI: 10.1161/circoutcomes.6.suppl_1.a172
Popis: OBJECTIVES: Heart Failure (HF) is a leading cause of morbidity and mortality. Hospitalization for HF appears to be steadily increasing. We sought to identify HF patients and understand their patterns of care in the “real-world” through analysis of a retrospective observational database. METHODS: Patients in the Medicare 5% database with a primary inpatient diagnosis of HF (428.0, 428.9, 428.20-23, 428.30-33, 428.40-43) during CY05-08 were included. Maximum follow-up was 33 months (6 months baseline, 3 month index and 24 months follow-up ). Minimum follow-up was 9 months . To exclude prevalent cases, patients were required to have no HF diagnoses during baseline. The quarter of the initial HF inpatient diagnosis was designated the “index”. Patients were followed for up to 2 years (8 Quarters) after the “index” or until death or enrolment end. Sub-cohorts were defined based on HF events experienced during follow-up: 0, 1, or 2 or more. RESULTS: 43,819 patients with new primary HF inpatient claims were identified in the study period. Within the 27 month follow-up (includes “index”), the identified HF patients had 140,802 inpatient hospitalizations (3.2 per patient), of which 67,339 (1.54 per patient) had a primary HF diagnosis (includes index HF hospitalization). Out of the 43,819 patients included, only 10,166 (23.2%) had one or more HF hospitalization within two years after the index period. Patients who experienced one or more than one HF admission after “index” tended to have experienced more all-cause admissions. Mortality was 10.3% during “index”; 25.3% in Year 1 and 14.0% in Year 2. Total mortality was 42.4% (18,562 out of 43,819). CONCLUSIONS: These results suggest that an early HF patient could be expected to get admitted on average 3.2 times for any cause over the next 2 years; 1.54 times for HF (47.8% of total). Mortality after the index HF admission was >40% over the same period. Our results further underline HF as a major clinical and economic burden in the US. More importantly, our results demonstrate that most of the economic burden is driven by a relatively small percentage of patients (23.2%); successful intervention in this subgroup could drastically reduce the burden of HF to Medicare.
Databáze: OpenAIRE